Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor

Metabolism: Clinical and Experimental

Volumn 45, Issue 12, 1996, Pages 1493-1500

  Desbois Mouthon, Christèle ^b   Danan, Claude ^b   Amselem, Serge ^b   Blivet Van Eggelpoel, Marie José ^b   Sert Langeron, Caroline ^b   Goossens, Michel ^b   Besmond, Claude ^b   Capeau, Jacqueline ^b   Caron, Martine ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; INSULIN RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C;

ARTICLE; AUTOPHOSPHORYLATION; CASE REPORT; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SYNTHESIS; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN RESISTANCE; LEPRECHAUNISM; MALE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030474865     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90178-X     Document Type: Article

References (48)

1. Ebina Y, Ellis L, Jarnagin K, et al: The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signaling. Cell 40:747-758, 1985
2. Ullrich A, Bell JR, Chen EY, et al: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-761, 1985
3. Cheatham B, Kahn CR: Insulin action and the insulin signaling network. Endocr Rev 16:117-142, 1995
4. Myers MG, Sun XJ, White MF: The IRS-1 signaling system. Trends Biochem Sci 19:289-293, 1994
5. Myers MG, White MF: New frontiers in insulin receptor substrate signaling. Trends Endocrinol Metab 6:209-215, 1995
6. Taylor SI: Molecular mechanisms of insulin resistance. Diabetes 41:1473-1490, 1992
7. Flier JS: Syndromes of insulin resistance. Diabetes 41:1207-1219, 1992
8. Donohue WL, Uchida I: Leprechaunism: A euphemism for a rare familial disorder. J Pediatr 45:505-519, 1954
9. Kadowaki T, Bevins CL, Cama A, et al: Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240:787-790, 1988
10. Kadowaki T, Kadowaki H, Accili D, et al: Substitution of arginine for histidine at position 209 in the α-subunit of the human insulin receptor. J Biol Chem 266:21224-21231, 1991
11. Maassen JA, Van der Vorm ER, Van der Zon GCM, et al: A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochemistry 30:10778-10783, 1991
12. Van der Vorm ER, Van der Zon GCM, Möller W, et al: An Arg for Gly substitution at position 31 in the insulin receptor, linked to insulin resistance, inhibits receptor processing and transport. J Biol Chem 267:66-71, 1982
13. Longo N, Langley SD, Griffin LD, et al: Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance. Am J Hum Genet 50:998-1007, 1992
14. Longo N, Langley SD, Griffin LD, et al: Activation of glucose transport by a natural mutation in the human insulin receptor. Proc Natl Acad Sci USA 90:60-64, 1993
15. Krook A, Brueton L, O'Rahilly S: Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 342:277-278, 1993
16. Van der Vorm ER, Kuipers A, Kielkopf-Renner S, et al: A mutation in the insulin receptor that impairs proreceptor processing but not insulin binding. J Biol Chem 269:14297-14302, 1994
17. Wertheimer E, Barbetti F, Muggeo M, et al: Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor. J Biol Chem 269:7587-7592, 1994
18. 281 in the α-subunit of the human insulin receptor causes constitutive activation of the receptor and insulin desensitization. J Clin Endocrinol Metab 81:719-727, 1996
19. Jospe N, Zhu J, Liu R, et al: Deletion of 3 basepairs resulting in the loss of lysine-121 in the insulin receptor α-subunit in a patient with leprechaunism: Binding, phosphorylation, and biological activity. J Clin Endocrinol Metab 79:1294-1302, 1994
20. Magré J, Reynet C, Capeau J, et al: In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Diabetes 37:421-428, 1988
21. Magré J, Grigorescu F, Reynet C, et al: Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 69:142-150, 1989
22. Caron M, Reynet C, Wicek D, et al: Insulin receptor mutation at tyrosines 1162 and 1163 alters both receptor serine phosphorylation and desensitization. Metabolism 43:757-765, 1994
23. Desbois C, Magré J, Blanquet V, et al: Detection of sequence variations in the human insulin-receptor gene by parallel denaturing gradient gel electrophoresis. Hum Mut 2:395-403, 1993
24. Kadowaki T, Kadowaki H, Taylor SI: A nonsense mutation causing decreased levels of insulin receptor mRNA: Detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction. Proc Natl Acad Sci USA 87:658-662, 1990
25. Müller-Wieland D, Van der Vorm ER, Streicher R, et al: An in-frame insertion in exon 3 and a nonsense mutation in exon 2 of the insulin receptor gene associated with severe insulin resistance in a patient with Rabson-Mendenhall syndrome. Diabetologia 36:1168-1174, 1993
26. Kusari J, Takata Y, Hatada E, et al: Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. J Biol Chem 266:5260-5267, 1991
27. 1174 → Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient. FEBS Lett 351:276-280, 1994
28. Kishimoto M, Hashiramoto M, Yonezawa K, et al: Substitution of glutamine for arginine 1131. J Biol Chem 269:11349-11355, 1994
29. Takahashi Y, Kadowaki H, Momomura K, et al: Identification of a homozygous mutation of the insulin receptor gene decreasing tyrosine kinase activity in a patient with leprechaunism. Diabetes 42:63A, 1993 (suppl 1, abstr)
30. Imamura T, Takata Y, Sasaoka T, et al: Two naturally occurring mutation in the kinase domain of insulin receptor accelerate degradation of the insulin receptor and impair the kinase activity. J Biol Chem 269:31019-31027, 1994
31. Hanks SK, Quinn AM, Hunter T: The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52, 1988
32. Hubbard SR, Wei L, Ellis L, et al: Crystal structure of the tyrosine kinase domain of the insulin receptor. Nature 372:746-754, 1994
33. 999) in exon 17 of the insulin receptor gene in a family with insulin resistance. J Clin Endocrinol Metab 79:1840-1844, 1994
34. Moller DE, Yokata A, White MF, et al: A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem 265:14979-14985, 1990
35. 1048 → Asp mutation in the kinase domain of insulin receptor causes defective kinase activity and insulin resistance. Diabetes 42:1837-1844, 1993
36. Cama A, Quon MJ, De la Luz Sierra M, et al: Substitution of isoleucine for methionine at position 1153 in the β-subunit of the human insulin receptor. J Biol Chem 267:8383-8389, 1992
37. Cama A, De la Luz Sierra M, Quon MJ, et al: Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. J Biol Chem 268:8060-8069, 1993
38. Odawara M, Kadowaki T, Yamamoto R, et al: Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science 245:66-68, 1989
39. Moller DE, Benecke H, Flier JS: Biologic activities of naturally occurring human insulin receptor mutations. J Biol Chem 266:10995-11001, 1991
40. Formisano P, Sohn KJ, Miele C, et al: Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action. J Biol Chem 268:5241-5248, 1993
41. Levy-Toledano R, Caro LHP, Accili D, et al: Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J 13:835-842, 1994
42. Tavaré JM, Siddle K: Mutational analysis of insulin receptor function: Consensus and controversy. Biochim Biophys Acta 1178: 21-39, 1993
43. Tanti JF, Gremeaux T, Van Obberghen E, et al: Serine/ threonine phosphorylation of insulin receptor substrate-1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057, 1994
44. Van Obberghen-Schilling EE, Rechler MM, Romanus JA, et al: Receptors for insulin-like growth factor I are defective in fibroblasts cultured from a patient with leprechaunism. J Clin Invest 68:1356-1365, 1981
45. Reddy SSK, Kahn CR: Epidermal growth factor receptor defects in leprechaunism. J Clin Invest 84:1569-1576, 1989
46. Longo N: Defective receptors for platelet-derived growth factor AA in human fibroblasts with mutant insulin receptors. Biochem Biophys Res Comm 197:812-817, 1993
47. Moller DE, O'Rahilly S: Syndromes of severe insulin resistance: Clinical and pathophysiological features, in Moller DE (ed): Insulin Resistance. New York, NY, Wiley, 1993, pp 49-81
48. Langlois WJ, Sasaoka T, Yip CC, et al: Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors. Endocrinology 136:1978-1986, 1995